JDRF Funds Clinical Trial to Test Pig Islet Cells

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies (LCT), a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness…. Read more

Successful First Trial for Artificial Pancreas

The new artificial pancreas system developed at Boston University was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of type 1 diabetic patients in the first clinical trial conducted at Massachusetts General Hospital…. Read more

Researchers Cure Type 1 Diabetes in Mice

Using a sophisticated nanotechnology-based “vaccine,” researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes… Read more

The Regeneration of Beta Cells

A new study shows alpha cells in the pancreas, the cells which secrete the hormone glucagon, can regenerate themselves into insulin-producing beta cells… Read more

European Artificial Pancreas On The Way

According to a JDRF press release, a consortium of academic and industrial partners has announced a collaboration called AP@home that aims to develop an artificial pancreas which would allow automated glucose control for people with insulin treated diabetes.
In the first phase of the AP@home project, currently available AP algorithms will be tested with CGM (continuous glucose monitoring) systems and insulin pumps… Read more

Subscribe to our Newsletter

Hide me